HUE033286T2 - Vezikulumok, amelyek tartalmaznak epidermális növekedési faktort, és készítmények, amelyek tartalmazzák azokat - Google Patents
Vezikulumok, amelyek tartalmaznak epidermális növekedési faktort, és készítmények, amelyek tartalmazzák azokat Download PDFInfo
- Publication number
- HUE033286T2 HUE033286T2 HUE13759116A HUE13759116A HUE033286T2 HU E033286 T2 HUE033286 T2 HU E033286T2 HU E13759116 A HUE13759116 A HU E13759116A HU E13759116 A HUE13759116 A HU E13759116A HU E033286 T2 HUE033286 T2 HU E033286T2
- Authority
- HU
- Hungary
- Prior art keywords
- top top
- egf
- vesicles
- céljából
- cholesterol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Diabetes (AREA)
- Materials Engineering (AREA)
- Physical Education & Sports Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Inorganic Chemistry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
Claims (5)
- WEEíKUEUMOK, amelyek tartalmaznak epidermális NÖVEKEDÉSI FAKTORT, ÉS KÉSZÍTMÉNYEK; AMELYEK TARTALMAZZÁK AZOKAT :i:iMhîidâïsîi igénypontok L \ ,v:ko. mirk, emu -ok tutt.dow,,\ik os's-vm,dts no-.cede..-* lakion dCFsx egy \ οιοπον tebsietai-m anxegot ocazuteo cs s-d, -./tonntχ aas amtal szánm/éhan I- kerubi t ka uo wu > - ?i abc t. o u » * ülnaktn i'-', ka d uaie'ik (mmonm"u ον o xu\t,' lo - ai* ' n ei letups m-eg no vu -Nateoiv nmioomem'ttpuNO, egy elvan teiUletaktn uns peinnh asovh o h>\ étkezőkből all«' csoportból van yàkîvîva: eytil-drimebíommRlniuro-broínid tCTAB), cetrhnid es tvo, alkom am -klot id >, H KO. S< \ ^ziLd eo*- ο 1 - χ N g >'p»mok > a- -i -i rn-> ín k< - mv eu-.t>ki' anyag uen/nn és .¾ Ok'niynn, -< ag) wo ér wnu -.-okán \<ν<et a lu Μ \ Μ-H>1 1 Μ ^ M- 5g terjedő u-kanéra on- tahihuo, > - a uviavus ie F( 4 0\ a kolON/to^n. sw annak Ν',ί η- Λ-'1 κ not u " nV Mi !k ki S' tk* u ate* O)h,m t -. Ye > 4- v&zikuUsmok ax 1-3. igénypontok bármelyike szerint, amelyek axzai vannak jellemezve, Ρ<ν) og\ soteye s e.l.oeenel On eg) b>,m kwie > mago- vlagON ovrettel rerklolk'-.'oek aa\ ' O' n s'Mîî w <! ahem elom-o-u n x' m on EiO wv-U taialtv A* Xtvikelumuk a/ .a gertyf-viok hnmehäke w mb ahol , FGF a '--/unlme ken \utegt*t - nu' -1 N*- o', kk'- Ί \ ar W , » - i -boopibo È \ oeikuhnnuk m 1 : y-t- uypnntok bfemehike $z*i n\ .melyek a: kon^riimk-öuidumcjíkaí ,él-elmaró teehooiogu 4T tee'mmh <j'a, angolul „co-mnav-NoU t'Fuid tCF) technology " > fOvesi i aonai ο! -.vins a, eh-ayósen ahol a CF-iu hsxdogta magúban b-gkd eg\ -ilμη on, -mely mágusban íoghdya a következőket, ;î; do F<IF è» eg) Kamm**n ídűíctaktn anyag <u.m<od) ogy noon »'klatunak az dőáliíi&Na, előnyösen aboi .a kationok felületaktív anyag (te.nzki) kvatemü ammonium-tipest'l, b'i a koleszterinnek vagy unnak a Nêârovazëkahiak a felnlkása cg) voervev uh.ldN?.erheo, amely egv CF- vel van cxp«m<iáiva, e' a vozíkmumoknak a Nzksuuuí-e ai'üfiak hogy > ο' Ιο$>ονΚΊ Noamm-o uidat οηοΓκηο onlkkenlve van (az nyomásmcmcsftve van) az a) lépésből kzirmaző oldaton s abban). ?,. ΚΜ-ο-ϊν vo/'-kíduíookísok <u' tloatlíUNaío, aoîtljok tusuh'nunO ki 1 ο , n latin <-tehUet'îkth ,eoíy<'t neo.-kk; is k-O-î/k oof, vagy annak o/armzokkalk azzal jellíUoe?u\ bogy az magâb;uv tngînhaa kôveîkezôket: as az I'3'îF On egy k-Ui-'n->- lolüíouktji -une-g üemnh eg\ ii/o,- -éduknuk az előállítás-, nUmyÖNon :«hoi a kationét; kéületakn'v anyag üenzid) kvatemer ánín-iénlum-tigt^«- b) a koleszterinnek vagy annak a származékainak a fdoklilsa egy szerves <.údé\,>eiixm, amely egy CF-vel van expandálva, elönyíkven ahol az oldószer a következőkből álló csoportból van választva: eg verték ő alkoholok, tőbfeéríekü alkoholok, ketonok, ekb“e .b- nm t-et <5it - vetet ,n ^ok ke'-e eket, om-ov ! e „4 e Cl ve' oh m noí'vüío* íí'íio1' \e, ttk'-οΌ '-mv iNZtva < ívoí \ 'an ptopa*' klőrozott-tluoroxou szénhidrogének i'hídtokdédltmroízéríhidrrtgéisrk, angolul οι i i 1 ot\ I » - ,n| uo N een.ixye >s\«Κκtoltut vntu <>g,tKk aitgoluk <,bydrotiuoroearbons'’}. el a vezikulumoknak a szintézise azaUah ía»gy a b) lépésűéi seamsa/o oldat nyonvha csökkentve van U-z tvyoisyhsneraesitve van) az a) lépésből s.ouinaz.ó oldaton tabktn.;. M H\ä'o\ * ' sgeex ,'/ js !'a ο ('Γ ^ î N.0! S i''osä meuielei a CF egy hozzá veröíeges mohőruének troólhanyadának, angolul: „molar reaction' \ amd> hö-nc n os-,ρ u-reè, ί.Ίοηχχνη.'η 0 5 «Ί 04 ö tened
- 9, EHárás a ?. vagy 8. igénypont szenm, ahol a koleszterinnek, vagy annak a ΐ ä' <o I ·, 11 \e ' η*4 ο !> χ mopxaloMl· î 'g' Ml\s »>> 80 Mpa-le îeriedô ho'zz.áxxnöieges nyomáson és agy olyan hozzávetőleges hőmersékielem amely kfinllbéíllí J0°0-íóí ?0 íí’-m terjed, előnyőse« MFC és 5CTC közök lalélhski
- 10. Elírás a ?*Ó igénypontok bármelyike szerint. ahol ne Eöl·· egv vizes oieatmtn vau +doi>Ea aoe \ mode s< i.x N n* nos vln elad x mx 'got lien/niet'» anal· egx olyan V s >t oo >' i0'4 '' $\ 'i'C \ .·> W s r ^dö \ » o*5* o»hk* mu» (o'V Ή»! vottal nnoeiiaí ^vnu'mtaooCO miest tai.dí.snk Π. övősvaszati készítmény. amely naittlnKuza ne 1-6. igénypontok bármelyike szerinti vexikulumoka* és legalább egy gyógyászai!Ing elfogadható segédanyagot (exctpfensi). 18 Vviiiivin <j ', ,utxoo '< * t a le elken ^ .mai «oiteno a.öydaM..! v'\ztenttf& .ioncd/ess/mul·. hnraiéziov maU’inUs. teptkohs. trmwxtenndl·. eUalnvskns mákon, xagx eg> mhalált Anmulaeiokem uwmómen\kém.>.
- 13. Vezikulumok a/. 1*6. igénypontok bármelyike szerint alkalmazás céljából egy gyógyszerként.
- 14. Wakulunx* tu t-6, igénypontok bármelyike szerint alk&lmM céljából u periiMIs lagyszóvmek komplex (kompul: ab t \éri.l kömnek a kezelésére. 15. v»",kai«mok alkalmaim ,,ο,.Κί x 14 mmv.pxuif veom. ahol a lomplov thompkkcVn' sérülés egy diaheteszes .láhfckély, vgy vénás fekély, egy dekubilosz-tetoei y (feliek vés-lekel· x.y \ oe t?p i 16* Yenkuhunuk tu 1-6. igénypontok bármelyike szerinipiâlkâlfiÉ^élèïlpMl· i.fnliÄkÄ k g.Oss elege hm-mgod ,¾ kezdésére. Π, Veztkuiumok az. 1-6. igénypontok bármelyike szerint alkalmazás céljából az emésztőrendszeri traktus lézióinak (sérüléseinek) a kezelésére, előnyőseit alkalmazás o..tp < vi K'xH> o,okítok <> kezde-mre mukozm«/ (usdkahaxu < j*yOÍUidaN}s dentaux kobtfsr uem x·. - χ mttaghx'i gx xthtnlato, deodenáhs lekel vek p\xombéltekdx\'k.í vagy disztáí Is koht.\< p'tvztxljk> v.}N<aghx>l-gxu»kt»l !·% m.gomi . űsníoí ^editC t 18. xeztkdu.ool. az I b >gs<nyf^xmok bátux'hike szemtk dteltpagil* céljából; a szero lézióinak {.sérüléseinekj a kezeléséret I#» KxVMVok.a teinnk. >onel·· tartuiawz/a az I o »μ*η\pontok narotdx tke scuxun Ό Miltxi \>kxr «'*. Veahhtx «Lgx \eeé a nagot { v »ptenstt. »0. \r 1 e eé.npent'k báuneuike sz»‘i*'Uí xe/ikuk«nokaak alkaimvUasji egx kuzmetika* leiroekia'k az. ekxaihtásan·.. előnyösen ahol a kozmetikai tennék egy olyan termek, amely a hör öregedésének és km'osod,isártak îelhasznàlb'Jàsânakï a megakadályozására szolgál.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CUP2012000112A CU24121B1 (es) | 2012-08-02 | 2012-08-02 | Vesículas que comprenden factor de crecimiento epidérmico y composiciones que las contienen |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE033286T2 true HUE033286T2 (hu) | 2017-11-28 |
Family
ID=49118249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE13759116A HUE033286T2 (hu) | 2012-08-02 | 2013-08-02 | Vezikulumok, amelyek tartalmaznak epidermális növekedési faktort, és készítmények, amelyek tartalmazzák azokat |
Country Status (27)
Country | Link |
---|---|
US (2) | US9717776B2 (hu) |
EP (1) | EP2915541B1 (hu) |
JP (1) | JP6251740B2 (hu) |
KR (1) | KR101752757B1 (hu) |
CN (1) | CN104684575B (hu) |
AR (1) | AR091951A1 (hu) |
AU (1) | AU2013299036C1 (hu) |
BR (1) | BR112015002103B1 (hu) |
CA (1) | CA2880404C (hu) |
CL (1) | CL2015000254A1 (hu) |
CU (1) | CU24121B1 (hu) |
DK (1) | DK2915541T3 (hu) |
ES (1) | ES2613087T3 (hu) |
HK (1) | HK1210970A1 (hu) |
HR (1) | HRP20170145T1 (hu) |
HU (1) | HUE033286T2 (hu) |
MX (1) | MX360674B (hu) |
MY (1) | MY196771A (hu) |
PL (1) | PL2915541T3 (hu) |
PT (1) | PT2915541T (hu) |
RS (1) | RS55713B1 (hu) |
RU (1) | RU2649781C2 (hu) |
SG (1) | SG11201500797SA (hu) |
SI (1) | SI2915541T1 (hu) |
UA (1) | UA113448C2 (hu) |
WO (1) | WO2014019555A1 (hu) |
ZA (1) | ZA201500763B (hu) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11712407B2 (en) * | 2014-12-30 | 2023-08-01 | Celltrion, Inc. | Hybrid-type multi-lamellar nanostructure of epidermal growth factor and liposome and method for manufacturing same |
US20180042847A1 (en) * | 2015-03-16 | 2018-02-15 | Duncan ROSS | Method of treatment comprising membrane-enclosed vesicle |
CN108699519A (zh) * | 2016-01-12 | 2018-10-23 | 康干细胞生物技术有限公司 | 干细胞衍生的含有大量生长因子的外来体 |
WO2017147407A1 (en) | 2016-02-25 | 2017-08-31 | Board Of Regents, The University Of Texas System | Compositions comprising composite nanocarriers and methods of making and uses thereof |
US11241480B2 (en) * | 2017-01-26 | 2022-02-08 | Washington University | Methods for modulation of dietary and microbial exposure with compositions comprising an EGFR ligand |
TWI636794B (zh) * | 2017-11-06 | 2018-10-01 | 吳治增 | 一種奈米複合材料及其應用 |
CU20190022A7 (es) * | 2019-03-18 | 2020-10-20 | Centro De Ingenieria Genetica Y Biotecnologia Biocubafarma | Composición farmacéutica para el tratamiento de la úlcera del pie diabético |
KR102636371B1 (ko) * | 2020-04-10 | 2024-02-19 | 한국과학기술연구원 | 신규 재조합 엑소좀 및 그의 용도 |
CN113827622B (zh) * | 2021-08-31 | 2023-11-07 | 南方医科大学 | 奇异变形杆菌外膜囊泡在制备预防或治疗骨溶解性疾病药物中的应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0272123A (ja) * | 1988-09-07 | 1990-03-12 | Hitachi Chem Co Ltd | ヒト上皮細胞成長因子の投与方法及びヒト上皮細胞成長因子含有疾病治療剤 |
US4944948A (en) | 1989-02-24 | 1990-07-31 | Liposome Technology, Inc. | EGF/Liposome gel composition and method |
US5064655A (en) * | 1989-02-24 | 1991-11-12 | Liposome Technology, Inc. | Liposome gel composition and method |
US5618544A (en) | 1992-08-12 | 1997-04-08 | Bays-Brown Dermatologics, Inc. | Method of decreasing cutaneous senescence |
US20020081324A1 (en) * | 2002-01-22 | 2002-06-27 | Twine Rebecca Wright | Method of treating aging skin and wrinkles using a combination of growth factors that is commercially prepared or derived from one's own blood |
WO2003090662A2 (en) * | 2002-04-25 | 2003-11-06 | Rapidheal, Inc. | Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease |
ES2265262B1 (es) * | 2005-01-31 | 2008-03-01 | Activery Biotech, S.L.(Titular Al 50%) | Procedimiento para la obtencion de sistemas micro- y nanodispersos. |
WO2007065464A1 (en) | 2005-12-09 | 2007-06-14 | Stichting Katholieke Universiteit | Epidermal growth factor (egf) derivatives with selectable selectivity for the erb receptor family |
CU23411B6 (es) | 2005-12-29 | 2009-09-08 | Ct Ingenieria Genetica Biotech | Uso tópico del factor de crecimiento epidérmico en liposomas para prevenir la amputación del pie diabético |
JP2009234945A (ja) * | 2008-03-26 | 2009-10-15 | Shalom:Kk | h−EGF含有スフィンゴミエリンリポソームおよびこれを配合した化粧料及び医薬品 |
CN102091034A (zh) * | 2009-12-15 | 2011-06-15 | 哈尔滨工业大学 | 基于胆固醇衍生物的有机-无机复合纳米囊泡的制备 |
KR101102834B1 (ko) * | 2010-02-24 | 2012-01-05 | 충남대학교산학협력단 | 신규한 리포좀 제조 방법 및 장치 |
EP2566583B1 (en) * | 2010-05-06 | 2018-07-11 | Regenics AS | Process for preparing fish egg cellular extract |
-
2012
- 2012-08-02 CU CUP2012000112A patent/CU24121B1/es active IP Right Grant
-
2013
- 2013-02-08 UA UAA201501774A patent/UA113448C2/uk unknown
- 2013-08-01 AR ARP130102727A patent/AR091951A1/es not_active Application Discontinuation
- 2013-08-02 AU AU2013299036A patent/AU2013299036C1/en active Active
- 2013-08-02 SG SG11201500797SA patent/SG11201500797SA/en unknown
- 2013-08-02 CA CA2880404A patent/CA2880404C/en active Active
- 2013-08-02 US US14/418,511 patent/US9717776B2/en active Active
- 2013-08-02 MY MYPI2015700300A patent/MY196771A/en unknown
- 2013-08-02 CN CN201380048721.3A patent/CN104684575B/zh active Active
- 2013-08-02 BR BR112015002103-4A patent/BR112015002103B1/pt active IP Right Grant
- 2013-08-02 MX MX2015001561A patent/MX360674B/es active IP Right Grant
- 2013-08-02 ES ES13759116.0T patent/ES2613087T3/es active Active
- 2013-08-02 SI SI201330504A patent/SI2915541T1/sl unknown
- 2013-08-02 PL PL13759116T patent/PL2915541T3/pl unknown
- 2013-08-02 KR KR1020157005385A patent/KR101752757B1/ko active IP Right Grant
- 2013-08-02 RS RS20170122A patent/RS55713B1/sr unknown
- 2013-08-02 DK DK13759116.0T patent/DK2915541T3/en active
- 2013-08-02 EP EP13759116.0A patent/EP2915541B1/en active Active
- 2013-08-02 WO PCT/CU2013/000004 patent/WO2014019555A1/es active Application Filing
- 2013-08-02 HU HUE13759116A patent/HUE033286T2/hu unknown
- 2013-08-02 RU RU2015106683A patent/RU2649781C2/ru active
- 2013-08-02 JP JP2015524635A patent/JP6251740B2/ja active Active
- 2013-08-02 PT PT137591160T patent/PT2915541T/pt unknown
-
2015
- 2015-02-02 CL CL2015000254A patent/CL2015000254A1/es unknown
- 2015-02-02 ZA ZA2015/00763A patent/ZA201500763B/en unknown
- 2015-12-03 HK HK15111950.8A patent/HK1210970A1/xx unknown
-
2017
- 2017-01-30 HR HRP20170145TT patent/HRP20170145T1/hr unknown
- 2017-07-31 US US15/664,548 patent/US11510965B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11510965B2 (en) | Vesicles comprising epidermal growth factor and compositions thereof | |
Grant et al. | DRV liposomal bupivacaine: preparation, characterization, and in vivo evaluation in mice | |
JP2015503565A (ja) | 安定化させたグルカゴンナノエマルジョン | |
Akram et al. | Design and development of insulin emulgel formulation for transdermal drug delivery and its evaluation | |
CA2911399A1 (en) | Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose | |
EP3512495B1 (en) | Prostacyclin analogue formulations | |
WO2008100629A2 (en) | Glutathione peroxidase mimetics for the treatment of dermatoses | |
CN113116825A (zh) | 用以制备麻醉剂组成物的脂质饼块及其制备方法 | |
JP5876191B2 (ja) | 安定なペキシガナン製剤 | |
CN115804771A (zh) | 一种具有长效缓释作用的脂质释药系统及其制备方法 | |
KR20130110326A (ko) | 칼시토닌의 경구투여용 조성물 |